Utah Medical Products, Inc. (NASDAQ:UTMD) Shares Acquired by JPMorgan Chase & Co.

JPMorgan Chase & Co. lifted its stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 10.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 69,411 shares of the medical instruments supplier’s stock after purchasing an additional 6,645 shares during the quarter. JPMorgan Chase & Co. owned about 2.05% of Utah Medical Products worth $4,644,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of UTMD. Minerva Advisors LLC raised its position in Utah Medical Products by 461.8% during the 3rd quarter. Minerva Advisors LLC now owns 42,328 shares of the medical instruments supplier’s stock worth $2,818,000 after buying an additional 34,794 shares during the last quarter. State Street Corp raised its holdings in Utah Medical Products by 0.9% during the third quarter. State Street Corp now owns 80,856 shares of the medical instruments supplier’s stock worth $5,434,000 after purchasing an additional 694 shares in the last quarter. Barclays PLC lifted its position in Utah Medical Products by 214.1% in the third quarter. Barclays PLC now owns 4,574 shares of the medical instruments supplier’s stock valued at $306,000 after purchasing an additional 3,118 shares during the period. Brandes Investment Partners LP lifted its position in Utah Medical Products by 66.2% in the second quarter. Brandes Investment Partners LP now owns 116,524 shares of the medical instruments supplier’s stock valued at $7,789,000 after purchasing an additional 46,427 shares during the period. Finally, BNP Paribas Financial Markets boosted its holdings in Utah Medical Products by 102.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock valued at $75,000 after purchasing an additional 566 shares in the last quarter. 69.60% of the stock is owned by institutional investors and hedge funds.

Utah Medical Products Stock Performance

Utah Medical Products stock opened at $62.16 on Friday. The company has a market cap of $210.85 million, a P/E ratio of 14.56 and a beta of 0.09. Utah Medical Products, Inc. has a one year low of $60.08 and a one year high of $84.10. The business has a fifty day moving average of $63.32 and a two-hundred day moving average of $65.80.

Utah Medical Products Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 3rd. Investors of record on Monday, December 16th were paid a $0.305 dividend. This is a boost from Utah Medical Products’s previous quarterly dividend of $0.30. The ex-dividend date was Monday, December 16th. This represents a $1.22 annualized dividend and a dividend yield of 1.96%. Utah Medical Products’s dividend payout ratio (DPR) is 28.57%.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 7th.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.